OSAS, T2DM
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Understanding and willing to participate in this clinical trial and to provide signed informed consent; 2. Aged 18-70 years male and female; 3. Newly diagnosed type 2 diabetes which meet the WHO recommendation (1999) standard;
Exclusion criteria
Exclusion criteria: Using drugs that affect glucose metabolism, unstable cardiopulmonary conditions, liver or renal disease, malignant tumor, neurological disorders, psychiatric disease, shift work, chronic insomnia, or any prior or current treatment for OSA (upper airway surgery, CPAP therapy, oral appliances, or supplemental oxygen), autoimmune disease, glaucoma or high intraocular tension, pregnant or breast-feeding women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Apnea Hyponea Index;oxygen desaturation index;HOMA-IR;Insulin sensitivity index;The 24-h mean blood glucose;Sleep structure;Mean nocturnal oxygen saturation; | — |
Countries
China
Contacts
Department of Endocrinology and Metabolism, West China Hospital, Sichuan University